Xuebo Pan
-
- Fibroblast Growth Factor Research 13
- Epigenetics and DNA Methylation 7
- Kruppel-like factors research 7
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 5
- Hepatology top 10%
- Liver physiology and pathology 2
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 2
-
- Alcohol Consumption and Health Effects 3
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Xiaokun LiZhuofeng LinAimin XuLeigang JinFan WuYu WangYi ZhangTingting Lü
- Partner nations
- ChinaHong KongSouth Korea
In The Last Decade
Xuebo Pan
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 638
- Epidemiology 287
- Hepatology 57
- Physiology 170
- Pharmacology 57
Countries citing papers authored by Xuebo Pan
This map shows the geographic impact of Xuebo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebo Pan more than expected).
Fields of papers citing papers by Xuebo Pan
This network shows the impact of papers produced by Xuebo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebo Pan. The network helps show where Xuebo Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuebo Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 43 | |
| 8 | 2018 | 128 | |
| 9 | 2018 | 14 | |
| 10 | 2017 | 8 | |
| 11 | 2017 | 22 | |
| 12 | 2017 | 8 | |
| 13 | 2015 | 18 | |
| 14 | 2015 | 172 | |
| 15 | 2014 | 108 | |
| 16 | 2014 | 30 | |
| 17 | 2014 | 44 | |
| 18 | 2012 | 50 | |
| 19 | 2012 | 10 | |
| 20 | 2011 | 27 |
About Xuebo Pan
Xuebo Pan is a scholar working on Hepatology, Nephrology and Epidemiology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (13 papers), Epigenetics and DNA Methylation (7 papers), Kruppel-like factors research (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Alcohol Consumption and Health Effects (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Liver physiology and pathology (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Molecular Biology (638 citations), Epidemiology (287 citations) and Hepatology (57 citations). Xuebo Pan has collaborated with scholars based in China, Hong Kong and South Korea. Frequent co-authors include Xiaokun Li, Zhuofeng Lin, Aimin Xu, Leigang Jin, Fan Wu, Yu Wang, Yi Zhang, Tingting Lü, Shaoqiang Lin and Fan Wu. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.